PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer

NEXT STORY
Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2018 Financial Results
PREV STORY
FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Invitation to the extraordinary shareholders’ meeting

PRESS RELEASE: REGULATED INFORMATIONWednesday, 9 August 2017, 07:00 CEST Invitation to the extraordinary shareholders' ...

author_avatar
NASDAQ Market News

Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results

Focusing TTI-621 clinical development on T-cell lymphomaTTI-621 received Orphan Drug Designation for the treatment ...

author_avatar
NASDAQ Market News

Pistol Bay Signs Exclusivity Agreement for Cannabinoid Herbal Blend

VANCOUVER, British Columbia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Pistol Bay Mining Inc. (TSX-V ...

author_avatar
NASDAQ Market News